Gary D. Steinberg MD, FACSProfessor and Director, Goldstein Bladder Cancer Program, NYU Langone Health, New York, New York
Dr. Steinberg earned his medical degree from the University of Chicago Medical School. He completed his internship, residency, and fellowship at the Johns Hopkins University School of Medicine in Baltimore, Maryland. While at Johns Hopkins, he was an American Cancer Society Clinical Fellow in urologic oncology.
He is actively involved in developing and performing innovative surgical procedures for patients with bladder, and kidney cancer. In addition to his surgical expertise, Dr. Steinberg coordinates all of the clinical trials for the Section of Urology at the University of Chicago Medicine and currently is enrolling patients in several innovative National Cancer Institute- and industry-funded studies for patients with bladder and kidney cancer. He is also the Chairman of the Department of Surgery clinical trials scientific advisory panel.
Dr. Steinberg is the chairperson of the scientific advisory board of the Bladder Cancer Advocacy Network, as well as executive member of the planning committee of the annual Bladder Cancer Think Tank meetings. He was recently recognized by the Journal of Urology as the "Best Reviewer" for his peer review of bladder cancer articles submitted to the Journal of Urology for publication as well as a member of the editorial board of Urologic Oncology. Furthermore, the Society of Urologic Oncology has awarded Dr. Steinberg and the University of Chicago an accreditation for Urologic Oncology Fellowship training.
Recent Contributions to PracticeUpdate:
- Persistent Muscle-Invasive Bladder Cancer After Neoadjuvant Chemotherapy
- Tolerability of Repeat Use of Blue Light Cystoscopy With Hexaminolevulinate in Urothelial Cell Carcinoma
- Incidental Prostate Cancer in Patients With Bladder Urothelial Carcinoma: Comprehensive Analysis of 1,476 Radical Cystoprostatectomy Specimens